In this video, CEO of Pila Pharma, Dorte X. Gram, interviews Matt Sondag about the thoughts and challenges of a living with #erythromelalgia, a rare disease with periods of intense pain.
In this video, CEO of Pila Pharma, Dorte X. Gram, interviews Ulla Taylor about the thoughts and challenges of a first time investor and how to subscribe shares in the ongoing financing round.
CEO Dorte X. Gram chats with Ulf Andersson, a long-time investor of PILA PHARMA about his motivations and interest in PILA, how he sees the company as investment, and how belief in the founder is critical.
CEO Dorte X. Gram interviews the recently appointed Director of New Projects in PILA PHARMA, Dr. Hans Quiding. Hans is an expert within Erythromelalgia specifically and analgesia in general, and has chosen to join the PILA PHARMA team to work on developing a pipeline around TRPV1. In this interview, Hans comments on his interest in PILA PHARMA, his outlook on the market for analgesic medication market and how a TRPV1 antagonist, like the one PILA PHARMA uses, could become a gamechanger.
CEO Dorte X. Gram interviews long-term shareholder Niels Raaschou discussing the history his interest/motivation for investing in PILA and the thoughts on the current new shares issue.
Today, Amanda Gustafsson from Nordic Issuing paid us a visit 🤗
Dorte X. Gram asked her about how one can subscribe in our ongoing rightsissue – pls, check it out